Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia-Reference-Cited by-同舟云学术

Intravenous and topical intranasal bevacizumab (Avastin) in hereditary hemorrhagic telangiectasia

Published:2012-05 Issue:3 Volume:33 Page:349-351
ISSN:0196-0709
Container-title:American Journal of Otolaryngology
language:en
Short-container-title:American Journal of Otolaryngology

Author:

Brinkerhoff Brian T.,Choong Nicholas W.,Treisman Jonathan S.,Poetker David M.

Publisher

Elsevier BV

Subject

Otorhinolaryngology

Reference11 articles.

1. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome);Shovlin;Am J Med Genet,2000

2. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor–beta1 as well as high ALK1 tissue expression;Sadick;Haematologica,2005

3. Dramatic improvement in hereditary hemorrhagic telangiectasia after treatment with the vascular endothelial growth factor (VEGF) antagonist bevacizumab;Flieger;Ann Hematol,2006

4. Bevacizumab in hereditary hemorrhagic telangiectasia;Bose;N Engl J Med,2009

5. Long-term therapy with bevacizumab in hereditary hemorrhagic telangiectasia;Brinkerhoff;N Engl J Med,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. European Reference Network for Rare Vascular Diseases (VASCERN): When and how to use intravenous bevacizumab in Hereditary Haemorrhagic Telangiectasia (HHT)?;European Journal of Medical Genetics;2022-10

Effect Of Bevacizumab On Growth Of Human Nasal Polyposis In Vitro; An Off-Label Use Of Anti-Angiogenic Agent For Nasal Polyposis Treatment

;Drug Design, Development and Therapy;2019-09

3. Does severe bleeding in HHT patients respond to intravenous bevacizumab? Review of the literature and case series;Rhinology journal;2019-01-01

4. Long-term experience with intranasal bevacizumab therapy;The Laryngoscope;2018-02-22

5. Pazopanib effective for bevacizumab-unresponsive epistaxis in hereditary hemorrhagic telangiectasia;The Laryngoscope;2018-02-16